EA202091873A3 - Способы лечения гипотонии - Google Patents

Способы лечения гипотонии

Info

Publication number
EA202091873A3
EA202091873A3 EA202091873A EA202091873A EA202091873A3 EA 202091873 A3 EA202091873 A3 EA 202091873A3 EA 202091873 A EA202091873 A EA 202091873A EA 202091873 A EA202091873 A EA 202091873A EA 202091873 A3 EA202091873 A3 EA 202091873A3
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
hypotonia
methods
hypotension
angiotensin
Prior art date
Application number
EA202091873A
Other languages
English (en)
Other versions
EA202091873A2 (ru
Inventor
Джордж Тидмарш
Original Assignee
Ла Хойя Фарма, Ллк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ла Хойя Фарма, Ллк filed Critical Ла Хойя Фарма, Ллк
Publication of EA202091873A2 publication Critical patent/EA202091873A2/ru
Publication of EA202091873A3 publication Critical patent/EA202091873A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к применению ангиотензина II в терапевтическом способе для лечения гипотонии, особенно, устойчивой к катехоламину гипотонии.
EA202091873A 2014-07-08 2015-07-08 Способы лечения гипотонии EA202091873A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462022054P 2014-07-08 2014-07-08

Publications (2)

Publication Number Publication Date
EA202091873A2 EA202091873A2 (ru) 2020-11-30
EA202091873A3 true EA202091873A3 (ru) 2021-01-29

Family

ID=55064810

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201692534A EA036514B1 (ru) 2014-07-08 2015-07-08 Способ лечения гипотонии
EA202091873A EA202091873A3 (ru) 2014-07-08 2015-07-08 Способы лечения гипотонии

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201692534A EA036514B1 (ru) 2014-07-08 2015-07-08 Способ лечения гипотонии

Country Status (14)

Country Link
US (3) US20160074465A1 (ru)
EP (2) EP3007722A4 (ru)
JP (2) JP2017519799A (ru)
KR (1) KR20170026486A (ru)
CN (1) CN106794224A (ru)
AU (2) AU2015287955A1 (ru)
BR (1) BR112017000303A2 (ru)
CA (1) CA2954016A1 (ru)
EA (2) EA036514B1 (ru)
IL (1) IL249936A0 (ru)
MX (1) MX2017000306A (ru)
SG (2) SG11201610897VA (ru)
TW (3) TW202214219A (ru)
WO (1) WO2016007589A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
CA2933601A1 (en) 2013-12-18 2015-06-25 The George Washington University, A Congressional Chartered Not-For-Prit Corporation Angiotensin ii alone or in combination for the treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
JP2019501201A (ja) 2016-01-07 2019-01-17 ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ アンジオテンシンｉｉの投与方法
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2019118874A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers
KR102258546B1 (ko) 2018-10-26 2021-06-01 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
CN101316626A (zh) * 2005-09-29 2008-12-03 菲布罗根公司 用于降低血压的方法
CN104398471A (zh) * 2008-11-28 2015-03-11 Abbvie公司 稳定的抗体组合物和用于稳定其的方法
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
CA2933601A1 (en) * 2013-12-18 2015-06-25 The George Washington University, A Congressional Chartered Not-For-Prit Corporation Angiotensin ii alone or in combination for the treatment of hypotension

Also Published As

Publication number Publication date
MX2017000306A (es) 2017-07-10
SG11201610897VA (en) 2017-01-27
TWI754225B (zh) 2022-02-01
EA202091873A2 (ru) 2020-11-30
US20160074465A1 (en) 2016-03-17
WO2016007589A1 (en) 2016-01-14
AU2021201669A1 (en) 2021-04-08
EP3007722A1 (en) 2016-04-20
AU2015287955A1 (en) 2017-02-02
CN106794224A (zh) 2017-05-31
BR112017000303A2 (pt) 2017-11-07
JP2020143139A (ja) 2020-09-10
SG10201804034QA (en) 2018-07-30
EA036514B1 (ru) 2020-11-18
IL249936A0 (en) 2017-03-30
TWI688385B (zh) 2020-03-21
EP3007722A4 (en) 2016-05-25
TW201625231A (zh) 2016-07-16
US20180311306A1 (en) 2018-11-01
EP3381465A1 (en) 2018-10-03
EA201692534A1 (ru) 2017-06-30
CA2954016A1 (en) 2016-01-14
JP2017519799A (ja) 2017-07-20
US20200237853A1 (en) 2020-07-30
TW202038927A (zh) 2020-11-01
TW202214219A (zh) 2022-04-16
KR20170026486A (ko) 2017-03-08

Similar Documents

Publication Publication Date Title
DK3389778T3 (da) Indretning til fotodynamisk behandling
EA202091873A3 (ru) Способы лечения гипотонии
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
DK3157527T3 (da) Ezh2-hæmmere til lymfombehandling
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3231444T3 (da) Ny behandling
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
LT3164394T (lt) Gls1 inhibitoriai, skirti ligų gydymui
DK3296485T3 (da) Ståldrager
PL3400000T3 (pl) Sposoby podawania angiotensyny ii
DK3302478T3 (da) Pac-1 kombinations behandling
EA201792527A1 (ru) Лечение зуда
EA201691036A1 (ru) Новое соединение для лечения тяжелой гипогликемии
EA201690914A1 (ru) Новое соединение для лечения тяжелой гипогликемии
DK3237407T3 (da) 3,5-diaminopyrazolkinasehæmmere
DK3795130T3 (da) Terapiapparat.
EA201700060A1 (ru) Терапевтическое средство для кератоконъюнктивальных расстройств
MA54630A (fr) N,n-bis-2-mercaptoéthyle isophtalamide pour le traitment des maladies neurodégénératives
DK2975004T3 (da) Syrespildevandsbehandling
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis
DK3250168T3 (da) Forbedringer vedrørende nethindebehandling
FI20155772A (fi) Menetelmä biolietteen käsittelemiseksi
TH1601002947A (th) โพลิออล-อิน-ออยล์-อิมัลชันสำหรับการนำส่งทางผิวหนัง
UA31684S (uk) Пристосування для обробки води